NEIL KUMAR - 24 Dec 2024 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Chief Executive Officer, Director
Signature
/s/ Brian C. Stephenson, Attorney-in-Fact
Issuer symbol
BBIO
Transactions as of
24 Dec 2024
Net transactions value
$0
Form type
4
Filing time
27 Dec 2024, 19:05:38 UTC
Previous filing
12 Dec 2024
Next filing
30 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Gift $0 -4,685,725 -96% $0.000000 211,718 24 Dec 2024 Direct
transaction BBIO Common Stock Gift $0 +4,685,725 +463% $0.000000 5,698,447 24 Dec 2024 By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee. F1
holding BBIO Common Stock 995,686 24 Dec 2024 By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose.